Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a randomized controlled trial with blinded evaluator and follow-up of one year. Seventy six patients with diffuse systemic sclerosis, will be randomized into two groups.The patients can not change their medication during the study. Patients will be evaluated at baseline and at 3, 6, 9 and 12 months. The experimental group will use a serial night time position splint who will be adjusted monthly, while the control group will remain the drug treatment. The outcomes assessed will be: pain, hand range of motion, quality of life, functional capacity, upper limb function and dexterity. Our hypothesis is that the serial night time position splint will improve the hand range of motion in diffuse systemic sclerosis patients.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Experimental Group | Experimental | Splint group |
|
| Control Group | Active Comparator | Drug treatment |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Serial night time position splint | Device | This group will use a serial night time position splint, adjusted monthly, during three months. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in hand range of motion | Measured by goniometry | Baseline and after 3, 6, 9 and 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Change in pain | Measured by a visual analogue scale | Baseline, after 10, 20 and 40 weeks |
| Change in functional capacity | Measured by HAQ questionnaire |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Fernanda P Cardoso, OT | Contact | 551155764239 | anamajones@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Jamil Natour, PhD | Federal University of São Paulo | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Universidade Federal de Sao Paulo | Recruiting | São Paulo | São Paulo | 04023-062 | Brazil |
Not provided
| ID | Term |
|---|---|
| D045743 | Scleroderma, Diffuse |
| ID | Term |
|---|---|
| D012595 | Scleroderma, Systemic |
| D003240 | Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D012871 | Skin Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Drug treatment | Drug | This patients will keep there drug treatment and will receive their splints on the end of the study. |
|
| Baseline, after 10, 20 and 40 weeks |
| Change in quality of life | Measured by SF-36 questionnaire | Basline, after 10, 20 and 40 weeks |
| Change in upper limb function | Measured by DASH questionnaire | Baseline, after 10, 20 and 40 weeks |
| Change in dexterity | Measured by SODA test | Baseline, after 3, 6, 9 and 12 months |